PPARγ has been shown to function as tumor suppressor in colon, lung, pancreatic, prostate and breast cancer, as increased PPARγ signaling in these diseases leads to reduced cellular growth and the inhibition of tumor invasiveness [61,62,63,64,65]. Here, PPARG is linked to breast carcinoma.